Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 02, 2026 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Aquestive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Aquestive Therapeutics urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/4/2026.
March 30, 2026 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Aquestive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Aquestive Therapeutics urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/4/2026.
March 26, 2026 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Aquestive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for AQST urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/4/2026.
March 23, 2026 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Aquestive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for AQST urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/4/2026.
March 19, 2026 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Aquestive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for AQST urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/4/2026.
March 16, 2026 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Aquestive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for AQST urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/4/2026.
March 12, 2026 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Aquestive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for AQST urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/4/2026.
March 09, 2026 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Aquestive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for AQST urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/4/2026.